ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Genocea Biosciences Inc

Genocea Biosciences Inc (GNCA)

0.051
0.00
(0.00%)
Closed September 23 4:00PM
0.00
0.00
(0.00%)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.051
Bid
0.01
Ask
0.05
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
0.051
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

GNCA Latest News

Genocea to Present at September Healthcare Conferences

CAMBRIDGE, Mass., Aug. 30, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, today announced that...

Genocea Provides Corporate Update, Including Second-Quarter 2019 Financial Results

Initiated Part B of Phase 1/2a clinical trial of neoantigen vaccine candidate GEN-009;Plans to present additional GEN-009 immunogenicity data at ESMO 2019 Conference call today at 8:30 am ET...

Genocea to Host Quarterly Corporate Update Conference Call & Webcast on July 25th at 8:30 am ET

CAMBRIDGE, Mass., July 18, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, will host its...

Genocea Announces Pricing of $36,750,000 Public Offering of Common Stock

CAMBRIDGE, Mass., June 19, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, today announced the...

Genocea Announces Proposed Public Offering of Common Stock

CAMBRIDGE, Mass., June 18, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, today announced that it...

Genocea’s GEN-009 Vaccine Demonstrates Best-in-Class Immune Responses to ATLAS™-selected Neoantigens in Cancer Patients

   Post-vaccination T cell responses detected to 91% of vaccine neoantigens, including CD8+ T cell responses to 53% of vaccine neoantigens Conference call and webcast to discuss results TODAY at...

Genocea’s GEN-009 Clinical Results Presentation Selected by ASCO’s Journal of Clinical Oncology® as a Top 10 Featured Im...

Poster presentation tomorrow, June 1st at 8:00 am CT in Poster Hall A Conference call and webcast to discuss results Monday, June 3rd at 8:30 am ET CAMBRIDGE, Mass., May 31, 2019 (GLOBE...

Genocea Announces Research Collaboration with Iovance to Explore Development of Neoantigen-Targeted TIL (Tumor-Infiltrating L...

CAMBRIDGE, Mass., May 16, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, today announced a...

Genocea Announces Positive Interim Immunogenicity Data from GEN-009 Neoantigen Vaccine Phase 1/2a Clinical Trial

Post-vaccination immune responses detected to 93% of vaccine neoantigens  in first three patients analyzed Additional data to be presented June 1st at ASCO 2019 and discussed on a conference call...

Genocea Provides Corporate Update, Including First-Quarter 2019 Financial Results

Company anticipates presenting first GEN-009 immunogenicity data at ASCO 2019 Conference call today at 9:00 am ET CAMBRIDGE, Mass., April 30, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
KAVLKaival Brands Innovations Group Inc
$ 1.33
(129.71%)
182.46M
LASELaser Photonics Corporation
$ 18.8671
(81.24%)
13.54M
TGLTreasure Global Inc
$ 1.18
(73.45%)
139.95M
NVVENuvve Holding Corporation
$ 6.68
(70.41%)
31.34M
UXINUxin Ltd
$ 2.42
(52.68%)
18.24M
ELABElevai Labs Inc
$ 0.10545
(-62.34%)
23.66M
ADTXAditxt Inc
$ 0.262
(-31.52%)
3.17M
FRGTFreight Technologies Inc
$ 0.081
(-28.82%)
26.35M
ANEBAnebulo Pharmaceuticals Inc
$ 2.23
(-27.60%)
113.78k
STSSSharps Technology Inc
$ 0.1722
(-27.06%)
2.27M
XPONExpion360 Inc
$ 0.1144
(34.91%)
432.17M
NVDANVIDIA Corporation
$ 116.26
(0.22%)
206.23M
INTCIntel Corporation
$ 22.56
(3.30%)
184.44M
KAVLKaival Brands Innovations Group Inc
$ 1.33
(129.71%)
182.46M
TGLTreasure Global Inc
$ 1.18
(73.45%)
139.95M

Discussion

View Full Feed
powerbattles powerbattles 5 minutes ago
Sometime in 2023 feels like a long wait. I rarely invest in OTC stocks and hold onto them for so long, but this one has all the ingredients I believe could lead to significant profits. Waiting is the hardest part. If making money were easy, patience wouldn’t be necessary.
EMGE
193638 193638 5 minutes ago
Lenny can suck it almost 3 billion shares now!!
INKW
wadegarret wadegarret 6 minutes ago
Mankind- TSSI insider sale

Does it bother you owning the stock at almost $7, when the Vice President sold 7% of his shares at $5.08 10 days ago ? How about the fact that the stock is up over 3000% in a few months, or has a 7+ PE going forward, even assuming a 10+ fold eps increase
TSSI
Doc logic Doc logic 6 minutes ago
norisknorewards,

If you want to announce something that costs more money than might be expected, you want data to back up the rational. The longer the data matures, the stronger someone else may look and the more time given for an opportunity by others to intervene and break up an in
NWBO
gfp927z gfp927z 7 minutes ago
Pfizer - >>> More than meets the eye

https://finance.yahoo.com/news/3-dirt-cheap-stocks-buy-113600626.html

Keith Speights (Pfizer): Pfizer has been a big loser in recent years, although it has eked out a meager gain in 2024. However, I believe there's more than meets th
Bizreader Bizreader 7 minutes ago
With all respect, what would Forrest Gump do at this point?
COOP
gfp927z gfp927z 8 minutes ago
Pfizer - >>> More than meets the eye

https://finance.yahoo.com/news/3-dirt-cheap-stocks-buy-113600626.html

Keith Speights (Pfizer): Pfizer has been a big loser in recent years, although it has eked out a meager gain in 2024. However, I believe there's more than meets th
gfp927z gfp927z 8 minutes ago
Pfizer - >>> More than meets the eye

https://finance.yahoo.com/news/3-dirt-cheap-stocks-buy-113600626.html

Keith Speights (Pfizer): Pfizer has been a big loser in recent years, although it has eked out a meager gain in 2024. However, I believe there's more than meets th
tredenwater2 tredenwater2 9 minutes ago
Here is a way to link up. Falconner I think you will soak this up if you havent already seen it.

Google below:

Dr. Jack Kruse and Andrew Huberman Youtube
AVXL
StayHumble StayHumble 10 minutes ago
10km00t🟩8km00t🟩ALJm00t 🟩JudgeFAV0RED$DBMM🟩
Meaning the ruling? +1

Source: https://www.sec.gov/alj/aljdec/2019/id1389cff.pdf
No available sanction appropriate|Thus Proceeding Dismissed.
-------------------------------V. OR
DBMM
ShawnP123 ShawnP123 11 minutes ago
Interesting how Microsoft got dinged for depending too much on Nvidia. Not a good scenario.
NVDA
Schrodingers Cat Schrodingers Cat 13 minutes ago
Sep 23 short volumes: CODX 48%, FLGT 37%, QDEL 80%, VERU 49%.
CODX VERU
georgejjl georgejjl 14 minutes ago
Watch the pre-market trading of AVXL this week!!!

Good luck and GOD bless,
AVXL
nycdream nycdream 14 minutes ago
Lots of potential and it’s cheap But company hasn’t done anything yet to increase shareholder value
MHRE
dinogreeves dinogreeves 14 minutes ago
When you have names like burrito, menedez and Jose Ole, know for sure this is a head to toe scam. Then you will be three wheeling to TJ soon.
BIEI
gfp927z gfp927z 15 minutes ago
>>> Hershey is turning its candy into energy drinks and protein powders with C4


CNN Business

by Jordan Valinsky

Sep 18, 2024


https://finance.yahoo.com/news/hershey-turning-candy-energy-drinks-130019084.html

HSY
dstock07734 dstock07734 15 minutes ago
The longs are certain you are heading for dead-end. You know that too. Your agitation index is spiking dramatically. It should end for you soon. Probably in two or three weeks.

Clueless and illiterate minion has no chance to win.
NWBO
gfp927z gfp927z 16 minutes ago
>>> Hershey is turning its candy into energy drinks and protein powders with C4


CNN Business

by Jordan Valinsky

Sep 18, 2024


https://finance.yahoo.com/news/hershey-turning-candy-energy-drinks-130019084.html

HSY
Acme Investments Acme Investments 16 minutes ago
Same formula guys!! When you least expect it.......Boom!!
FNMA
gfp927z gfp927z 16 minutes ago
>>> Hershey is turning its candy into energy drinks and protein powders with C4


CNN Business

by Jordan Valinsky

Sep 18, 2024


https://finance.yahoo.com/news/hershey-turning-candy-energy-drinks-130019084.html

HSY
fink fink 16 minutes ago
You got a room for your personal ball washer.

I know how you golfers
IGPK
excel excel 19 minutes ago
Whole lot better passing then when with the Viks.

Some will say because he was hurt back then. OK, so why are you playing when you hurting your team?

PS ............ Bengals defense SUCKS!
doc2016 doc2016 19 minutes ago
intel got 3+billion from dod for chips........sbv/vcsy ip? but does it have to be hardware? like for apple make it software ai for iphone 16?
chklingon chklingon 19 minutes ago
Very nice start to the week.
TSLA
littlejohn littlejohn 20 minutes ago
NOG .42/share quarterly dividend soon,

goes ex-div on Friday, 27th...

NOG,20%, and VTLE,80%, closed

on their respective ownership in the

new, Point, deal that was pending...

NOG big acquisition in Unita Basin

Your Recent History

Delayed Upgrade Clock